Base6Base 6GAAP revenue YoY +4.59% → base 6. The base score is anchored to the GAAP revenue YoY band before transcript, EPS, and guidance adjustments.+Transcript0Transcript 0GAAP revenue is clean, no distortion. Danaher is a life sciences/diagnostics company not in the Sector Rules Table.+EPS0EPS 0GAAP EPS YoY +12.75% vs revenue YoY +4.59%, GAAP spread +8.16pp (outside +5pp). OI YoY -13.97%, OI spread -18.56pp (outside -5pp, opposite direction). OI contaminated by ~$150M+ Q4 productivity investments/restructuring charges sitting on the operating line. Management reports adjusted EPS up approximately 4%, adjusted spread = 4.0 - 4.59 = -0.59pp (inside ±5pp). Per core/adjusted EPS shortcut rule → 0.+Guidance+1Guidance +1Annual-cycle Q4 fiscal year-end: new FY2026 guidance introduced for the first time — 3% to 6% core revenue growth and $8.35 to $8.50 adjusted diluted EPS. New forward-year guidance on growth metrics → +1.=Final7